Protective immune response in mice vaccinated with a recombinant adenovirus containing capsid precursor polypeptide P1, nonstructural protein 2A and 3C protease genes (P12A3C) of encephalomyocarditis virus

Vaccine

Volumn 26, Issue 4, 2008, Pages 573-580

  Chen, Zhenhai ^a   Guo, Xin ^a   Ge, Xinna ^a   Jia, Hong ^a   Yang, Hanchun ^a  

^a AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

Author keywords

Encephalomyocarditis virus (EMCV); Protective immune response; Recombinant adenoviruses

Indexed keywords

BETA GALACTOSIDASE; CAPSID PROTEIN; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 2A; NONSTRUCTURAL PROTEIN 3C; POLYPEPTIDE P1; PROTEIN PRECURSOR; PROTEIN VP1; PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENCEPHALOMYOCARDITIS VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; IMMUNE RESPONSE; IMMUNOPEROXIDASE STAINING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINATION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CAPSID PROTEINS; CARDIOVIRUS INFECTIONS; CELL LINE; CYSTEINE ENDOPEPTIDASES; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; GENETIC VECTORS; HUMANS; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PROTEIN PRECURSORS; RECOMBINATION, GENETIC; VACCINATION; VACCINES, DNA; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 37849013365     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.027     Document Type: Article

References (35)

1. Rueckert R.R. Picornaviridae: the viruses and their replication. In: Fields B.N., Knipe D.M., Howley P.M., Chanock R.M., Melnick J.L., Monath T.P., et al. (Eds). Fields virology. 3rd ed. (1996), Lippincott-Raven Press, Philadephia, PA 609-654
2. Murnane T.G., Craighead J.E., Mondragon H., and Shelokov A. Fatal disease of swine due to encephalomyocarditis virus. Science 131 (1960) 498-499
3. Koenen F. Encephalomyocarditis virus. In: Straw B.E., Zimmerman J.J., Allaire S.D., and Taylor D.J. (Eds). Diseases of swine (2006), Blackwell Publishing Professional, Iowa 331-336
4. Kluivers M., Maurice H., Vyt P., Koenen F., and Nielen M. Transmission of encephalomyocarditis virus in pigs estimated from field data in Belgium by means of R0. Vet Res 37 (2006) 757-766
5. Billinis C., Paschaleri-Papadopoulou E., Psychas V., Vlemmas J., Leontides S., Koumbati M., et al. Persistence of encephalomyocarditis virus (EMCV) infection in piglets. Vet Microbiol 70 (1999) 171-177
6. Koenen F., De Clercq K., Lefebvre J., and Strobbe R. Reproductive failure in sows following experimental infection with a Belgian EMCV isolate. Vet Microbiol 39 (1994) 111-116
7. Koenen F., Vanderhallen H., Castryck F., and Miry C. Epidemiologic, pathogenic and molecular analysis of recent encephalomyocarditis outbreaks in Belgium. Zentralbl Veterinarmed B 46 (1999) 217-231
8. Love R.J., and Grewal A.S. Reproductive failure in pigs caused by encephalomyocarditis virus. Aust Vet J 63 (1986) 128-129
9. Acland H.M., and Littlejohns I.R. Encephalomyocarditis virus infection of pigs. 1. An outbreak in New South Wales. Aust Vet J 51 (1975) 409-415
10. Koenen F., Vanderhallen H., Papadopoulos O., Billinis C., Paschaleri-Papadopoulou E., Brocchi E., et al. Comparison of the pathogenic, antigenic and molecular characteristics of two encephalomyocarditis virus (EMCV) isolates from Belgium and Greece. Res Vet Sci 62 (1997) 239-244
11. Sidoli L., Barigazzi G., Foni E., Marcato P.S., and Barbieri G. Encephalomyocarditis (EMC) due to cardiovirus in Po Valley swines: preliminary observations. 1. Clinical aspects, virus isolation, characterization and experimental transmission. Selozoine Vet 30 (1989) 249-260
12. Dea S., Bilodeau R., Sauvageau R., and Martineau G.P. Outbreaks in Quebec pig farms of respiratory and reproductive problems associated with encephalomyocarditis virus. J Vet Diagn Invest 3 (1991) 275-282
13. Maurice H., Nielen M., Brocchi E., Nowotny N., Kassimi L.B., Billinis C., et al. The occurrence of encephalomyocarditis virus (EMCV) in European pigs from 1990 to 2001. Epidemiol Infect 133 (2005) 547-557
14. Maurice H., Nielen M., Vyt P., Frankena K., and Koenen F. Factors related to the incidence of clinical encephalomyocarditis virus (EMCV) infection on Belgian pig farms. Prev Vet Med 78 (2007) 24-34
15. Brewer L., Brown C., Murtaugh M.P., and Njenga M.K. Transmission of porcine encephalomyocarditis virus (EMCV) to mice by transplanting EMCV-infected pig tissues. Xenotransplantation 10 (2003) 569-576
16. Denis P., Liebig H.D., Nowotny N., Billinis C., Papadopoulos O., O'Hara R.S., et al. Genetic variability of encephalomyocarditis virus (EMCV) isolates. Vet Microbiol 113 (2006) 1-12
17. Wells S.K., Gutter A.E., Soike K.F., and Baskin G.B. Encephalomyocarditis virus: epizootic in a zoological garden. J Zoo Wildlife Med 20 (1989) 291-296
18. Hunter P., Swanepoel S.P., Esterhuysen J.J., Raath J.P., Bengis R.G., and van der Lugt J.J. The efficacy of an experimental oil-adjuvanted encephalomyocarditis vaccine in elephants, mice and pigs. Vaccine 16 (1998) 55-61
19. Huneke R.B., Michaels M.G., Kaufman C.L., and Ildstad S.T. Antibody response in baboons (Papio cynocephalus anubis) to a commercially available encephalomyocarditis virus vaccine. Lab Anim Sci 48 (1998) 526-528
20. Zimmerman J.J. Encephalomyocarditis. In: Beran G.W. (Ed). Handbook of zoonoses (1994), CRC Press, Boca Raton, FL 423-436
21. Suh Y.S., Ha S.J., Lee C.H., Sin J.I., and Sung Y.C. Enhancement of VP1-specific immune responses and protection against EMCV-K challenge by co-delivery of IL-12 DNA with VP1 DNA vaccine. Vaccine 19 (2001) 1891-1898
22. Sin J.I., Sung J.H., Suh Y.S., Lee A.H., Chung J.H., and Sung Y.C. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: effect of coinjection with a granulocyte-macrophage colony stimulating factor gene. Vaccine 15 (1997) 1827-1833
23. Osorio J.E., Hubbard G.B., Soike K.F., Girard M., van der Werf S., Moulin J.C., et al. Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus. Vaccine 14 (1996) 155-161
24. Choi B.K., Cho S.H., Bai G.H., Kim S.J., Hyun B.H., Choe Y.K., et al. Prevention of encephalomyocarditis virus-induced diabetes by live recombinant Mycobacterium bovis bacillus Calmette-Guerin in susceptible mice. Diabetes 49 (2000) 1459-1467
25. Jun H.S., Yoon S.W., Kang Y., Pak C.Y., Lee M.C., and Yoon J.W. Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein. J Gen Virol 76 (1995) 2557-2566
26. Ge X.N., Yang H.C., Guo X., Lv Y.L., Wang F., Chen Y.H., et al. Isolation and characterization of porcine encephalomyocarditis virus. Acta Veterinaria et Zootechnica Sinica 38 (2007) 59-65
27. Dong X.X., Guo X., Yang H.C., Ge X.N., Chen Y.H., and Zha Z.L. Preparation and identification of monoclonal antibodies against VP1 protein of porcine encephalomyocarditis virus. Vet Sci (China) 37 (2007) 24-28
28. Zhang G.Q., Ge X.N., Guo X., and Yang H.C. Genomic analysis of two porcine encephalomyocarditis virus strains isolated in China. Arch Virol 152 (2007) 1209-1213
29. Reed L.J., and Muench H. A simple method of estimating fifty percent end-points. Am J Hyg 27 (1938) 493-497
30. Ge X.N., Yang H.C., Guo X., Chen Y.H., and Zha Z.L. Cloning and expression of structural protein VP1 gene of encephalomyocarditis virus. Chin J Vet Med 42 (2006) 9-11
31. Zhang J.L., Ge X.N., Ma L., Chen Y.H., Zha Z.L., Guo X., et al. Serological survey of EMCV infection in pigs on large-scale pig farms in China 2005-2006. Chin J Vet Med 43 (2007) 7-9
32. Mayr G.A., Chinsangaram J., and Grubman M.J. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate. Virology 263 (1999) 496-506
33. McLelland D.J., Kirkland P.D., Rose K.A., Dixon R.J., and Smith N. Serologic responses of Barbary sheep (Ammotragus lervia), Indian antelope (Antilope cervicapra), wallaroos (Macropus robustus), and chimpanzees (Pan troglodytes) to an inactivated encephalomyocarditis virus vaccine. J Zoo Wildlife Med 36 (2005) 69-73
34. Neal Z.C., and Splitter G.A. Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies. J Virol 72 (1998) 8052-8060
35. Neal Z.C., and Splitter G.A. Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies. J Virol 69 (1995) 4914-4923